Gynica
PrivateLast Round
Seed
Jun 24, 2021
Est. Valuation
$7.75M
Total Funding Raised
$1.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gynica is a clinical-stage biotech company that develops non-hormonal, cannabinoid-based therapeutic solutions for endometriosis and other gynecological conditions using its proprietary IntraVag drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gynica Comparables
Compare Gynica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Calla Lily Clinical Care | 81% | |
| FimmCyte | 76% | |
| Gesynta Pharma AB | 76% | |
Gynica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 1306% MoM, reaching 1.7K.
- Nov 6, 2025
Monthly visitors grew 78% MoM, from 693 to 1.2K.
Gynica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gynica's valuation, stock price, and market status.